Officials of the Guidant projected in an internal report that some patients might die as a result of short circuits in a company heart device, but it did not publicize the flaw because it apparently viewed the overall failure rate as acceptable, company records filed in connection with a lawsuit show.

New York Times (http://www.nytimes.com/2005/12/24/business/24guidant.html?pagewanted=print)